Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan T. Hirsch

Showing results (11-20 of 149) with videos related to

Pageof 15
Sort By:
Circulation|November 3, 2004
The continuum of risk: vascular pathophysiology, function, and structureAlan T Hirsch, Aaron R Folsom
Vascular Medicine (London, England)|April 25, 2003
Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reductionAlan T Hirsch, Antonio M Gotto
Advances in Chronic Kidney Disease|December 3, 2014
Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomesPranav S Garimella, Alan T Hirsch
Current Treatment Options in Cardiovascular Medicine|May 9, 2001
Intermittent ClaudicationAlan T. Hirsch, Laura M Reich
Vascular Medicine (London, England)|November 4, 2016
The conundrum of ALI and systemic embolic events: SEEing our way to improved vascular healthAlan T Hirsch, Jeremy R Van't Hof, Marc Bonaca
Patient Preference and Adherence|August 15, 2015
Recruiting older patients with peripheral arterial disease: evaluating challenges and strategiesDiana P Brostow, Alan T Hirsch, Mindy S Kurzer
Circulation|September 24, 2008
"POBA Plus": will the balloon regain its luster?Timothy D Henry, Robert S Schwartz, Alan T Hirsch
Expert Opinion on Investigational Drugs|January 9, 2003
Developing pharmaceutical treatments for peripheral artery diseaseDaniel A Duprez, Marc L De Buyzere, Alan T Hirsch
Vascular Medicine (London, England)|August 9, 2008
National health care costs of peripheral arterial disease in the Medicare populationAlan T Hirsch, Lacey Hartman, Robert J Town, et al.
The New England Journal of Medicine|December 13, 2002
Exercise training for claudicationKerry J Stewart, William R Hiatt, Judith G Regensteiner, et al.
Pageof 15

Showing results (11-20 of 149) with videos related to

Sort By:
Pageof 15
Circulation|November 3, 2004
The continuum of risk: vascular pathophysiology, function, and structureAlan T Hirsch, Aaron R Folsom
Vascular Medicine (London, England)|April 25, 2003
Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reductionAlan T Hirsch, Antonio M Gotto
Advances in Chronic Kidney Disease|December 3, 2014
Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomesPranav S Garimella, Alan T Hirsch
Current Treatment Options in Cardiovascular Medicine|May 9, 2001
Intermittent ClaudicationAlan T. Hirsch, Laura M Reich
Vascular Medicine (London, England)|November 4, 2016
The conundrum of ALI and systemic embolic events: SEEing our way to improved vascular healthAlan T Hirsch, Jeremy R Van't Hof, Marc Bonaca
Patient Preference and Adherence|August 15, 2015
Recruiting older patients with peripheral arterial disease: evaluating challenges and strategiesDiana P Brostow, Alan T Hirsch, Mindy S Kurzer
Circulation|September 24, 2008
"POBA Plus": will the balloon regain its luster?Timothy D Henry, Robert S Schwartz, Alan T Hirsch
Expert Opinion on Investigational Drugs|January 9, 2003
Developing pharmaceutical treatments for peripheral artery diseaseDaniel A Duprez, Marc L De Buyzere, Alan T Hirsch
Vascular Medicine (London, England)|August 9, 2008
National health care costs of peripheral arterial disease in the Medicare populationAlan T Hirsch, Lacey Hartman, Robert J Town, et al.
The New England Journal of Medicine|December 13, 2002
Exercise training for claudicationKerry J Stewart, William R Hiatt, Judith G Regensteiner, et al.
Pageof 15